Conscious sedation for awake fibreoptic intubation: A review of the literature

Canadian Journal of Anesthesia

Volumn 60, Issue 6, 2013, Pages 584-599

  Johnston, Kevin D ^a,b   Rai, Mridula R ^c  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; DIAZEPAM; DROPERIDOL; FENTANYL; KETAMINE; MIDAZOLAM; MORPHINE; OPIATE; PLACEBO; PROPOFOL; REMIFENTANIL;

ABSENCE OF SIDE EFFECTS; ADVERSE OUTCOME; AIRWAY OBSTRUCTION; AWAKE FIBREOPTIC INTUBATION; BOLUS INJECTION; BRADYCARDIA; CONCENTRATION RESPONSE; CONSCIOUS SEDATION; COUGHING; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; GENERAL ANESTHESIA; HEART RATE; HUMAN; HYPOTENSION; HYPOXIA; INTUBATION; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; OXYGEN DESATURATION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TOPICAL ANESTHESIA;

CONSCIOUS SEDATION; DEXMEDETOMIDINE; FIBER OPTIC TECHNOLOGY; HUMANS; HYPNOTICS AND SEDATIVES; INTUBATION, INTRATRACHEAL; PIPERIDINES; WAKEFULNESS;

EID: 84878722052     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-013-9915-9     Document Type: Review

References (72)

1. Ovassapian A, Yelich SJ, Dykes MH, Brunner EE. Fiberoptic nasotracheal intubation - incidence and causes of failure. Anesth Analg 1983; 62: 692-5.
2. Ovassapian A, Yelich SJ, Dykes MH, Brunner EE. Blood pressure and heart rate changes during awake fibreoptic nasotracheal intubation. Anesth Analg 1983; 62: 951-4.
3. Ovassapian A, Krejcie TC, Yelich SJ, Dykes MH. Awake fibreoptic intubation in the patient at high risk of aspiration. Br J Anaesth 1989; 62: 13-6.
4. Sidhu VS, Whitehead EM, Ainsworth QP, Smith M, Calder I. A technique of awake fibreoptic intubation. Experience in patients with cervical spine disease. Anaesthesia 1993; 48: 910-3.
5. Reasoner DK, Warner DS, Todd MM, Hunt SW, Kirchner J. A comparison of anesthetic techniques for awake intubation in neurosurgical patients. J Neurosurg Anesthesiol 1995; 7: 94-9.
6. Joo HS, Kapoor S, Rose DK, Naik VN. The intubating laryngeal mask airway after induction of general anesthesia versus awake fiberoptic intubation in patients with difficult airways. Anesth Analg 2001; 92: 1342-6.
7. Lee JH, Han SW, Kim YY, Yeom KW. Sedation and hemodynamic stability during fiberoptic awake nasotracheal intubation: comparison between propofol infusion and intravenous boluses of fentanyl and midazolam (Korean). Korean J Anesthesiol 1997; 33: 741-9.
8. Huitink JM, Balm AJ, Keijzer C, Buitelaar DR. Awake fibrecapnic intubation in head and neck cancer patients with difficult airways: new findings and refinements to the technique. Anaesthesia 2007; 62: 214-9.
9. Neidhart G, Bremerich DH, Kessler P. Fiberoptic intubation during remifentanil propofol sedation (German). Anaesthesist 2001; 50: 242-7.
10. Rai MR, Parry TM, Dombrovskis A, Warner OJ. Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blind randomised controlled trial. Br J Anaesth 2008; 100: 125-30.
11. Lallo A, Billard V, Bourgain JL. A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesth Analg 2009; 108: 852-7.
12. Zhang X, He W, Wu X, Zhou X, Huang W, Feng X. TCI remifentanil vs. TCI propofol for awake fiber-optic intubation with limited topical anesthesia. Int J Clin Pharmacol Ther 2012; 50: 10-6.
13. Tsai CJ, Chu KS, Chen TI, Lu DV, Wang HM, Lu IC. A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia 2010; 65: 254-9.
14. Donaldson AB, Meyer-Witting M, Roux A. Awake fibreoptic intubation under remifentanil and propofol target-controlled infusion. Anaesth Intensive Care 2002; 30: 93-5.
15. La Colla L, La Colla G, Albertin A, Poli D, Baruffaldi Preis FW, Mangano A. The use of propofol and remifentanil for the anaesthetic management of a super-obese patient. Anaesthesia 2007; 62: 842-5.
16. Cafiero T, Esposito F, Fraioli G, et al. Remifentanil-TCI and propofol-TCI for conscious sedation during fibreoptic intubation in the acromegalic patient. Eur J Anaesthesiol 2008; 25: 670-4.
17. Randell T, Valli H, Lindgren L. Effects of alfentanil on the responses to awake fiberoptic nasotracheal intubation. Acta Anaesthesiol Scand 1990; 34: 59-62.
18. Bailey PL, Pace NL, Ashburn MA, Moll JW, East KA, Stanley TH. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology 1990; 73: 826-30.
19. Brock-Utne JG, Winning TJ, Rubin J, Kingston HG. Laryngeal incompetence during neuroleptanalgesia in combination with diazepam. Br J Anaesth 1976; 48: 699-701.
20. Kapila A, Glass PS, Jacobs JR, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 1995; 83: 968-75.
21. Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (G187084B). Anesth Analg 1993; 77: 1031-40.
22. Burkle H, Dunbar S, Van Aken H. Remifentanil: a novel, short acting, mu-opioid. Anesth Analg 1996; 83: 646-51.
23. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II Model application. Anesthesiology 1997; 86: 24-33.
24. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I Model development. Anesthesiology 1997; 86: 10-23.
25. Machata AM, Gonano C, Holzer A, et al. Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and hemodynamic stability during conscious sedation with remifentanil. Anesth Analg 2003; 97: 904-8.
26. Reusche MD, Egan TD. Remifentanil for conscious sedation and analgesia during awake fiberoptic tracheal intubation: a case report with pharmacokinetic simulations. J Clin Anesth 1999; 11: 64-8.
27. Puchner W, Obwegeser J, Puhringer FK. Use of remifentanil for awake fiberoptic intubation in a morbidly obese patient with severe inflammation of the neck. Acta Anaesthesiol Scand 2002; 46: 473-6.
28. Puchner W, Egger P, Puhringer F, Lockinger A, Obwegeser J, Gombotz H. Evaluation of remifentanil as single drug for awake fiberoptic intubation. Acta Anaesthesiol Scand 2002; 46: 350-4.
29. Hagberg CA, Lam NC, Abramson SI, Vahdat K, Craig J. Dexmedetomidine vs. remifentanil for sedation in awake intubations. A randomized, double-blind trial. Anesthesiology 2008; 109: A14 (abstract).
30. Moerman AT, Herregods LL, De Vos MM, Mortier EP, Struys MM. Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients. Anesth Analg 2009; 108: 828-34.
31. De Castro V, Godet G, Mencia M, Raux M, Coriat P. Target-controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement. Anesth Analg 2003; 96: 33-8.
32. Olofsen E, Boom M, Nieuwenhuijs D, et al. Modeling the non-steady state respiratory effects of remifentanil in awake and propofol-sedated healthy volunteers. Anesthesiology 2010; 112: 1382-95.
33. Song JW, Kwak YL, Lee JW, Chang CH, Kim HS, Shim YH. The optimal effect site concentration of remifentanil in combination with intravenous midazolam and topical lidocaine for awake fibreoptic nasotracheal intubation in patients undergoing cervical spine surgery. Minerva Anestesiol 2012; 78: 521-6.
34. Avramov M, Smith I, White PF. Interactions between midazolam and remifentanil during monitored anesthesia care. Anesthesiology 1996; 85: 1283-9.
35. Vennila R, Hall A, Ali M, Bhuiyan N, Pirotta D, Raw DA. Remifentanil as single agent to facilitate awake fibreoptic intubation in the absence of premedication. Anaesthesia 2011; 66: 368-72.
36. Mingo OH, Ashpole KJ, Irving CJ, Rucklidge MW. Remifentanil sedation for awake fibreoptic intubation with limited application of local anaesthetic in patients for elective head and neck surgery. Anaesthesia 2008; 63: 1065-9.
37. Scheinin M, Schwinn DA. The locus coeruleus. Site of hypnotic actions of alpha 2-adrenoceptor agonists? Anesthesiology 1992; 76: 873-5.
38. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effect of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93: 382-94.
39. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54: 1136-42.
40. Kulka PJ, Tryba M, Zenz M. Difficult airway management in a patient with severe aortic stenosis, coronary artery disease, and heart failure. J Clin Anesth 2002; 14: 150-3.
41. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992; 77: 1125-33.
42. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000; 90: 699-705.
43. Bergese SD, Bender SP, McSweeney TD, Fernandez S, Dzwonczyk R, Sage K. A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. J Clin Anesth 2010; 22: 35-40.
44. Bergese SD, Candiotti K, Zura A, Bokesch PM, Bekker AY. Dexmedetomidine for sedation during elective fiberoptic intubation: a multicenter trial. Anesthesiology 2008; 109: A186 (abstract).
45. Chu KS, Wang FY, Hsu HT, Lu IC, Wang HM, Tsai CJ. The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. Eur J Anaesthesiol 2010; 27: 36-40.
46. Bergese SD, Khabiri B, Roberts WD, Howie MB, McSweeney TD, Gerhardt MA. Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. J Clin Anesth 2007; 19: 141-4.
47. Kunisawa T, Nagashima M, Hanada S, Suzuki A, Takahata O, Iwasaki H. Awake intubation under sedation using target-controlled infusion of dexmedetomidine: five case reports. J Anesth 2010; 24: 789-92.
48. Grant SA, Breslin DS, MacLeod DB, Gleason D, Martin G. Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three cases. J Clin Anesth 2004; 16: 124-6.
49. Boyd BC, Sutter SJ. Dexmedetomidine sedation for awake fiberoptic intubation of patients with difficult airways due to severe odontogenic cervicofacial infections. J Oral Maxillofac Surg 2011; 69: 1608-12.
50. Abdelmalak B, Makary L, Hoban J, Doyle DJ. Dexmedetomidine as sole sedative for awake intubation in management of the critical airway. J Clin Anesth 2007; 19: 370-3.
51. Avitsian R, Lin J, Lotto M, Ebrahim Z. Dexmedetomidine and awake fiberoptic intubation for possible cervical spine myelopathy: a clinical series. J Neurosurg Anesthesiol 2005; 17: 97-9.
52. Sriganesh K, Ramesh VJ, Veena S, Chandramouli BA. Dexmedetomidine for awake fibreoptic intubation and awake self-positioning in a patient with a critically located cervical lesion for surgical removal of infra-tentorial tumour. Anaesthesia 2010; 65: 949-51.
53. Neumann MM, Davio MB, Macknet MR, Applegate RL 2nd. Dexmedetomidine for awake fiberoptic intubation in a parturient with spinal muscular atrophy type III for cesarean delivery. Int J Obstet Anesth 2009; 18: 403-7.
54. Shah TH, Badve MS, Olajide KO, Skorupan HM, Waters JH, Vallejo MC. Dexmedetomidine for an awake fiber-optic intubation of a parturient with Klippel-Feil syndrome, type I Arnold Chiari malformation and status post released tethered spinal cord presenting for repeat cesarean section. Clinics Pract 2011; 1: e57.
55. Jooste EH, Ohkawa S, Sun LS. Fiberoptic intubation with dexmedetomidine in two children with spinal cord impingements. Anesth Analg 2005; 101: 1248.
56. Stamenkovic DM, Hassid M. Dexmedetomidine for fiberoptic intubation of a patient with severe mental retardation and atlantoaxial instability. Acta Anaesthesiol Scand 2006; 50: 1314-5.
57. Madhere M, Vangura D, Saidov A. Dexmedetomidine as sole agent for awake fiberoptic intubation in a patient with local anesthetic allergy. J Anesth 2011; 25: 592-4.
58. Maroof M, Khan RM, Jain D, Ashraf M. Dexmedetomidine is a useful adjunct for awake intubation. Can J Anesth 2005; 52: 776-7.
59. Cooper L, Samson R, Gallagher C, Barron M, Candiotti K. Dexmedetomidine provides excellent sedation for elective awake fiberoptic intubation. Anesthesiology 2005; 103: A1449 (abstract).
60. Scher CS, Gitlin MC. Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fibreoptic intubation. Can J Anesth 2003; 50: 607-10.
61. Unger RJ, Gallagher CJ. Dexmedetomidine sedation for awake fibreoptic intubation. Semin Anesth Perioper Med Pain 2006; 25: 65-70.
62. Patel A, Pearce A. Progress in management of the obstructed airway. Anaesthesia 2011; 66(Suppl 2): 93-100.
63. Shaw IC, Welchew EA, Harrison BJ, Michael S. Complete airway obstruction during awake fibreoptic intubation. Anaesthesia 1997; 52: 582-5.
64. McGuire G, El-Beheiry H. Complete upper airway obstruction during awake fibreoptic intubation in patients with unstable cervical spine fractures. Can J Anesth 1999; 46: 176-8.
65. Ho AM, Chung DC, To EW, Karmakar MK. Total airway obstruction during local anesthesia in a non-sedated patient with a compromised airway. Can J Anesth 2004; 51: 838-41.
66. Belda I, Cubas MG, Rivas E, Valero R, Martínez-Pallí G, Balust J. Remifentanil target controlled infusion (TCI) vs ketamine or ketamine in combination with remifentanil TCI for conscious sedation in awake fiberoptic intubation: a randomized controlled trial: 19AP1-5. Eur J Anaesthesiol 2011; 28: 226 (abstract).
67. Kopman AF, Wallman SB, Ross K, Surks SN. Awake endotracheal intubation: a review of 267 cases. Anesth Analg 1975; 54: 323-7.
68. Davis JL. Fiberoptic 'awake' nasal intubation: physiological and personal concepts. J Neurosci Nurs 1988; 20: 198-200.
69. Patil V, Barker GL, Harwood RJ, Woodall NM. Training course in local anaesthesia of the airway and fibreoptic intubation using course delegates as subjects. Br J Anaesth 2002; 89: 586-93.
70. Woodall NM, Harwood RJ, Barker GL. Complications of awake fibreoptic intubation without sedation in 200 healthy anaesthetists attending a training course. Br J Anaesth 2008; 100: 850-5.
71. Yeganeh N, Roshani B, Azizi B, Almasi A. Target-controlled infusion of remifentanil to provide analgesia for awake nasotracheal fiberoptic intubations in cervical trauma patients. J Trauma 2010; 69: 1185-90.
72. Sutherland AD, Williams RT. Cardiovascular responses and lidocaine absorption in fiberoptic-assisted awake intubation. Anesth Analg 1986; 65: 389-91.